Q2 2025 Holdings
Filed 2025-08-14 | 42 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $400.9M | 8,494,151 | 29.9% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $78.3M | 8,325,000 | 5.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $69.1M | 1,600,000 | 5.1% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $68.3M | 1,625,000 | 5.1% |
| Merus N V | COM | N5749R100 | $58.9M | 1,120,000 | 4.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $55.7M | 4,251,992 | 4.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $54.3M | 540,000 | 4.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $52.7M | 800,000 | 3.9% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $39.4M | 2,175,000 | 2.9% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $34.7M | 1,500,000 | 2.6% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $33.4M | 2,940,921 | 2.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $33.1M | 350,000 | 2.5% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $30.9M | 2,909,000 | 2.3% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $27.7M | 1,059,331 | 2.1% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $27.4M | 2,086,600 | 2.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $25.6M | 1,454,660 | 1.9% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $24.5M | 2,009,482 | 1.8% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $19.2M | 1,100,000 | 1.4% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $16.4M | 2,375,000 | 1.2% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $16.3M | 2,130,000 | 1.2% |
| CG Oncology Inc(CGON) | COM | 156944100 | $16.3M | 625,000 | 1.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $14.0M | 1,000,000 | 1.0% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $13.9M | 3,381,277 | 1.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $12.2M | 300,000 | 0.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $11.5M | 400,000 | 0.9% |
| Metsera Inc | COM | 59267L107 | $11.4M | 400,000 | 0.8% |
| Aardvark Therapeutics Inc(AARD) | COM | 002942100 | $10.8M | 800,189 | 0.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $10.4M | 100,000 | 0.8% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $8.8M | 2,140,605 | 0.7% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $8.5M | 2,323,595 | 0.6% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $8.0M | 700,000 | 0.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $7.6M | 5,000,000 | 0.6% |
| Alumis Inc(ALMS) | COM | 022307102 | $6.4M | 2,147,396 | 0.5% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $6.4M | 3,570,872 | 0.5% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $5.8M | 465,000 | 0.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $5.7M | 175,000 | 0.4% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $5.7M | 200,000 | 0.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $4.0M | 200,000 | 0.3% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.9M | 254,161 | 0.2% |
| Kala BIO Inc(KALA) | COM NEW | 483119202 | $2.9M | 603,027 | 0.2% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $2.3M | 1,370,938 | 0.2% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $141.1K | 10,000 | 0.0% |